- Report
- January 2026
- 240 Pages
Global
From €3104EUR$3,500USD£2,704GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2473EUR$2,789USD£2,155GBP
- Report
- October 2025
- 160 Pages
Global
From €2977EUR$3,358USD£2,594GBP
€3503EUR$3,950USD£3,052GBP
- Report
- December 2025
- 150 Pages
Global
From €4301EUR$4,850USD£3,747GBP
- Report
- October 2025
- 150 Pages
Global
From €4301EUR$4,850USD£3,747GBP
- Report
- August 2025
- 150 Pages
Global
From €4301EUR$4,850USD£3,747GBP
- Report
- September 2025
- 110 Pages
Global
From €3500EUR$4,228USD£3,156GBP
- Report
- August 2025
- 199 Pages
Global
From €3144EUR$3,545USD£2,739GBP
€3493EUR$3,939USD£3,043GBP
- Report
- April 2026
- 278 Pages
Global
From €5188EUR$5,850USD£4,520GBP
- Report
- February 2026
- 250 Pages
Global
From €3982EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €3982EUR$4,490USD£3,469GBP
- Report
- January 2024
- 150 Pages
Global
From €5276EUR$5,950USD£4,597GBP
- Report
- April 2024
- 115 Pages
Global
From €3990EUR$4,500USD£3,477GBP
- Report
- August 2022
- 120 Pages
Global
From €3990EUR$4,500USD£3,477GBP
- Report
- March 2024
- 200 Pages
Global
From €3680EUR$4,150USD£3,206GBP
- Report
- December 2024
- 152 Pages
Global
From €3503EUR$3,950USD£3,052GBP
- Report
- December 2024
- 30 Pages
Global
From €2439EUR$2,750USD£2,125GBP
- Report
- July 2024
- 150 Pages
Global
From €3325EUR$3,750USD£2,897GBP
- Report
- June 2024
- 200 Pages
Global
From €7050EUR$7,950USD£6,142GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2660EUR$3,000USD£2,318GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more